Opsonic IgG antibody against Actinobacillus actinomycetemcomitans in localized juvenile periodontitis.

PubWeight™: 1.23‹?› | Rank: Top 10%

🔗 View Article (PMID 2762021)

Published in Oral Microbiol Immunol on June 01, 1989

Authors

P J Baker, M E Wilson

Articles citing this

Evidence that the serotype b antigenic determinant of Actinobacillus actinomycetemcomitans Y4 resides in the polysaccharide moiety of lipopolysaccharide. Infect Immun (1991) 1.44

Immunoglobulin G subclass response of localized juvenile periodontitis patients to Actinobacillus actinomycetemcomitans Y4 lipopolysaccharide. Infect Immun (1992) 1.29

The heat-modifiable outer membrane protein of Actinobacillus actinomycetemcomitans: relationship to OmpA proteins. Infect Immun (1991) 1.17

Serum immunoglobulin G subclass concentrations in periodontally healthy and diseased individuals. Infect Immun (1994) 1.10

Role of the capsular polysaccharide-like serotype-specific antigen in resistance of Actinobacillus actinomycetemcomitans to phagocytosis by human polymorphonuclear leukocytes. Infect Immun (1995) 1.07

Immunoglobulin G2 antibodies promote neutrophil killing of Actinobacillus actinomycetemcomitans. Infect Immun (1995) 0.99

Immunoglobulin G subclass response of juvenile periodontitis subjects to principal outer membrane proteins of Actinobacillus actinomycetemcomitans. Infect Immun (1995) 0.99

Serum antibody in Actinobacillus actinomycetemcomitans-infected patients with periodontal disease. Infect Immun (1991) 0.96

Hyper-immunoglobulin G2 production by B cells from patients with localized juvenile periodontitis and its regulation by monocytes. Infect Immun (1996) 0.90

Regulation of immunoglobulin G2 production by prostaglandin E(2) and platelet-activating factor. Infect Immun (2000) 0.89

Aggregatibacter actinomycetemcomitans, a potent immunoregulator of the periodontal host defense system and alveolar bone homeostasis. Mol Oral Microbiol (2015) 0.87

Opsonic antibody activity against Actinobacillus actinomycetemcomitans in patients with rapidly progressive periodontitis. Infect Immun (1992) 0.84

Genetic segregation analyses of serum IgG2 levels. Am J Hum Genet (1996) 0.83

Immune response to cytolethal distending toxin of Aggregatibacter actinomycetemcomitans in periodontitis patients. J Periodontal Res (2010) 0.82

Effect of treatment on titer, function, and antigen recognition of serum antibodies to Actinobacillus actinomycetemcomitans in patients with rapidly progressive periodontitis. Infect Immun (1994) 0.81

Opsonization of Actinobacillus actinomycetemcomitans by immunoglobulin G antibody reactive with phosphorylcholine. Infect Immun (2002) 0.79

Subinhibitory concentrations of cefpodoxime alter membrane protein expression of Actinobacillus actinomycetemcomitans and enhance its susceptibility to killing by neutrophils. Antimicrob Agents Chemother (1995) 0.76

Opsonization of Actinobacillus actinomycetemcomitans by immunoglobulin G antibodies to the O polysaccharide of lipopolysaccharide. Infect Immun (1997) 0.75

Articles by these authors

(truncated to the top 100)

Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA (1994) 14.96

Use of erythrocytes sensitized with purified pneumococcal polysaccharides for the assay of antibody and antibody-producing cells. Appl Microbiol (1969) 5.29

Genetic control of the antibody response to type 3 pneumococcal polysaccharide in mice. I. Evidence that an X-linked gene plays a decisive role in determining responsiveness. J Exp Med (1972) 5.19

Bacon therapy and furuncular myiasis. JAMA (1993) 4.79

The efficacy of bacillus Calmette-Guérin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature. Pediatrics (1995) 4.72

Evidence for the existence of two functionally distinct types of cells which regulate the antibody response to type 3 pneumococcal polysaccharide. J Immunol (1970) 3.94

Carbohydrate fermentation plate medium for confirmation of Neisseria species. J Clin Microbiol (1975) 3.89

A new medium for the isolation of pathogenic Neisseria (NYC medium). I. Formulation and comparisons with standard media. Health Lab Sci (1973) 3.66

Malaria infection of the placenta in The Gambia, West Africa; its incidence and relationship to stillbirth, birthweight and placental weight. Trans R Soc Trop Med Hyg (1983) 3.46

Circulating concentrations of nocturnal leptin, growth hormone, and insulin-like growth factor-I increase before the onset of puberty in agonadal male monkeys: potential signals for the initiation of puberty. J Clin Endocrinol Metab (2000) 3.38

Orotracheal intubation in patients with potential cervical spine injuries. An indication for the gum elastic bougie. Anaesthesia (1993) 2.98

Predicting difficult intubation. Br J Anaesth (1993) 2.87

Isolation of Neisseria meningitidis from the Genito-urinary tract and anal canal. J Clin Microbiol (1975) 2.76

Characterization of the antibody response to type 3 pneumococcal polysaccharide at the cellular level. I. Dose-response studies and the effect of prior immunization on the magnitude of the antibody response. Immunology (1971) 2.74

Enhancement of the antibody response to type 3 pneumococcal polysaccharide in mice treated with antilymphocyte serum. J Immunol (1970) 2.59

A new medium for the isolation of pathogenic Neisseria (NYC medium). II. Effect of amphotericin B and trimethoprim lactate on selectivity. Health Lab Sci (1973) 2.58

The structure of Pyrococcus furiosus glutamate dehydrogenase reveals a key role for ion-pair networks in maintaining enzyme stability at extreme temperatures. Structure (1995) 2.56

A survey of anaesthetic misadventures. Anaesthesia (1981) 2.40

Emergence of gentamicin- and methicillin-resistant Staphylococcus aureus strains in New York City hospitals. J Clin Microbiol (1981) 2.39

Evaluation of tuberculosis control policies using computer simulation. JAMA (1996) 2.32

Hypoferremia in mice and its application to the bioassay of endotoxin. J Bacteriol (1965) 2.25

Modification by sialic acid of Neisseria gonorrhoeae lipooligosaccharide epitope expression in human urethral exudates: an immunoelectron microscopic analysis. J Infect Dis (1990) 2.22

Chemical composition and biological properties of the endotoxin of Brucella abortus. J Bacteriol (1965) 2.21

Molecular basis of triclosan activity. Nature (1999) 2.18

Sox9 coordinates a transcriptional network in pancreatic progenitor cells. Proc Natl Acad Sci U S A (2007) 2.15

Problems with the Mallampati sign. Anaesthesia (1990) 2.15

Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis. Int J Tuberc Lung Dis (2000) 2.15

A randomized controlled trial of prenatal pediatric visits for urban, low-income families. Pediatrics (1996) 2.14

Regulation of the antibody response to type 3 pneumococcal polysaccharide. I. Nature of regulatory cells. J Exp Med (1973) 2.11

A mechanism of drug action revealed by structural studies of enoyl reductase. Science (1996) 2.03

Antibiotic activity and characterization of BB-3497, a novel peptide deformylase inhibitor. Antimicrob Agents Chemother (2001) 2.01

Brevity of the inductive phase in the immune response of mice to capsular polysaccharide antigens. J Immunol (1967) 1.97

The selectivity of vancomycin and lincomycin in NYC medium for the recovery of N. gonorrhoeae from clinical specimens. Health Lab Sci (1978) 1.95

The need for global action against multidrug-resistant tuberculosis. JAMA (1999) 1.94

A comparison of grating visual acuity, strabismus, and reoperation outcomes among children with aphakia and pseudophakia after unilateral cataract surgery during the first six months of life. J AAPOS (2001) 1.93

Estradiol modulates bcl-2 in cerebral ischemia: a potential role for estrogen receptors. J Neurosci (1999) 1.90

Oxidative responses of human and murine macrophages during phagocytosis of Leishmania chagasi. J Immunol (2001) 1.90

Regulation of the antibody response to type 3 pneumococcal polysaccharide. II. Mode of action of thymic-derived suppressor cells. J Immunol (1974) 1.84

Coexistence of static magnetism and superconductivity in SmFeAsO(1-x)F(x) as revealed by muon spin rotation. Nat Mater (2009) 1.79

Overcrowding and other crises: how can we survive? J Emerg Nurs (2001) 1.69

Pediatrician interview style and mothers' disclosure of psychosocial issues. Pediatrics (1994) 1.67

Conformational flexibility in glutamate dehydrogenase. Role of water in substrate recognition and catalysis. J Mol Biol (1993) 1.67

In-home injury prevention practices for infants and toddlers: the role of parental beliefs, barriers, and housing quality. Health Educ Q (1995) 1.67

Complement and the direct mediation of immune glomerular injury: a new perspective. Kidney Int (1985) 1.67

Adrenocorticotropic hormone directly stimulates testosterone production by the fetal and neonatal mouse testis. Endocrinology (2003) 1.65

Unilateral intraocular lens implantation during the first six months of life. J AAPOS (1999) 1.64

Genetic control of the antibody response to type 3 pneumococcal polysaccharide in mice. II. Relationship between IgM immunoglobulin levels and the ability to give an IgM antibody response. J Exp Med (1974) 1.64

Magnetic and non-magnetic phases of a quantum spin liquid. Nature (2011) 1.63

Regulation of the antibody response to pneumococcal polysaccharide by thymus-derived cells. Rev Infect Dis (1981) 1.62

Evidence for cyclic development and short-lived maturity in the gametocytes of Plasmodium falciparum. Trans R Soc Trop Med Hyg (1971) 1.61

Characterization of the antibody response to type 3 pneumococcal polysaccharide at the cellular level. II. Studies on the relative rate of antibody synthesis and release by antibody-producing cells. Immunology (1971) 1.55

Spatial and temporal summation in impaired regions of the visual field. J Physiol (1967) 1.55

Homeostatic control of antibody responses: a model based on the recognition of cell-associated antibody by regulatory T cells. Transplant Rev (1975) 1.55

Crystal structure of DNA recombination protein RuvA and a model for its binding to the Holliday junction. Science (1996) 1.54

Rupture of the anterior lens capsule in Alport syndrome. J AAPOS (1999) 1.53

Randomized trial of enhanced anticipatory guidance for injury prevention. Arch Pediatr Adolesc Med (2001) 1.52

Projections from the lateral geniculate nucleus in the cat and monkey. J Anat (1967) 1.49

Location, transcription, and sequence of a baculovirus gene encoding a small arginine-rich polypeptide. J Virol (1987) 1.49

Requirement of B7 costimulation for Th1-mediated inflammatory bone resorption in experimental periodontal disease. J Immunol (2000) 1.49

Spin waves and revised crystal structure of honeycomb iridate Na2IrO3. Phys Rev Lett (2012) 1.49

Glycerol dehydrogenase. structure, specificity, and mechanism of a family III polyol dehydrogenase. Structure (2001) 1.48

Relationship between social factors and pituitary-adrenocortical activity in female rhesus monkeys (Macaca mulatta). Horm Behav (1993) 1.48

Protection against gram-negative infections with antiserum to lipid A from Salmonella minnesota R595. Infect Immun (1974) 1.47

Evidence that Leishmania donovani utilizes a mannose receptor on human mononuclear phagocytes to establish intracellular parasitism. J Immunol (1986) 1.47

Surgery on the normal eye in Duane retraction syndrome. J Pediatr Ophthalmol Strabismus (1994) 1.46

Social support and cancer screening in African American, Hispanic, and Native American women. Cancer Pract (1999) 1.44

Confirmation of confocal microscopy diagnosis of Acanthamoeba keratitis using polymerase chain reaction analysis. Arch Ophthalmol (2000) 1.44

Plasma immunoglobulin concentrations in an African (Gambian) community in relation to season, malaria and other infections and pregnancy. Clin Exp Immunol (1970) 1.43

Complement membrane attack complex stimulates production of reactive oxygen metabolites by cultured rat mesangial cells. J Clin Invest (1986) 1.42

Kinetics of the antibody response to type III pneumococcal polysaccharide. I. Evidence that suppressor cells function by inhibiting the recruitment and proliferation of antibody-producing cells. J Immunol (1976) 1.42

Changes in Leydig cell gene expression during development in the mouse. Biol Reprod (2002) 1.42

Structural and genetic analyses of O polysaccharide from Actinobacillus actinomycetemcomitans serotype f. Infect Immun (2001) 1.41

Intraocular lenses for children in the year 2000: when is oversight by the institutional review board or food and drug administration required? J AAPOS (2000) 1.41

Characterization of the antibody response to type 3 pneumococcal polysaccharide at the cellular level. 3. Studies on the average avidity of the antibody produced by specific plaque-forming cells. J Immunol (1971) 1.40

Emerging lessons of the Interdisciplinary Generalist Curriculum (IGC) Project. Acad Med (1998) 1.39

How safe is safe enough? New infections and the U.S. blood supply. Ann Intern Med (1992) 1.39

Direct evidence for the involvement of T suppressor cells in the expression of low-dose paralysis to type III pneumococcal polysaccharide. J Immunol (1982) 1.39

Regulation of the antibody response to type 3 pneumococcal polysaccharide. IV. Role of suppressor T cells in the development of low-dose paralysis. J Immunol (1974) 1.38

Analysis of a flawed double-blind, placebo-controlled, clinical trial of patients claimed to have persistent Lyme disease following treatment. Minerva Med (2009) 1.38

Testing the radiochemical purity of technetium Tc 99m-labeled radiopharmaceuticals. Am J Health Syst Pharm (1995) 1.37

Predictive value of regression and theoretical IOL formulas in pediatric intraocular lens implantation. J Pediatr Ophthalmol Strabismus (1997) 1.34

Regulation of the antibody response to type 3 pneumococcal polysaccharide. 3. Role of regulatory T cells in the development of an IgG and IgA antibody response. J Immunol (1974) 1.34

Bilateral intraocular lens implantation in the pediatric population. Ophthalmology (2000) 1.33

Early histopathology of experimental infection with Leishmania donovani in hamsters. J Parasitol (1987) 1.32

Increased enzymatic activity of the alternative pathway convertase when bound to the erythrocytes of paroxysmal nocturnal hemoglobinuria. J Clin Invest (1982) 1.32

A comparison of horse, cow, and sheep blood in NYC medium: effect on recovery of N. gonorrhoeae and urogenital mycoplasmas. Health Lab Sci (1976) 1.29

Intraocular lens implantation: has it become the standard of care for children? Ophthalmology (1996) 1.27

Minireview: neuroprotective effects of estrogen-new insights into mechanisms of action. Endocrinology (2001) 1.26

Targeted disruption of the methionine synthase gene in mice. Mol Cell Biol (2001) 1.26

Detection of terminal complement components in experimental immune glomerular injury. Kidney Int (1984) 1.24

Neonatal treatment with low doses of anti-idiotypic antibody leads to the expression of a silent clone. J Exp Med (1981) 1.24

A biochemical approach to periodontal regeneration: tetracycline treatment of dentin promotes fibroblast adhesion and growth. J Periodontal Res (1986) 1.24

Estradiol is a protective factor in the adult and aging brain: understanding of mechanisms derived from in vivo and in vitro studies. Brain Res Brain Res Rev (2001) 1.24

TGF-beta mediates CTLA-4 suppression of cellular immunity in murine kalaazar. J Immunol (2000) 1.24

Strain differences in the ability of antithymocyte serum (ATS) to enhance the antibody response of inbred mice to type 3 pneumococcal polysaccharide. Cell Immunol (1973) 1.23

Cloning, mapping and RNA analysis of the human methionine synthase gene. Hum Mol Genet (1996) 1.23

Regulation of the antibody response to type III pneumococcal polysaccharide. V. Ontogeny of factors influencing the magnitude of the plaque-forming cell response. J Immunol (1976) 1.22

Genetics and visceral leishmaniasis: of mice and man. Parasite Immunol (2009) 1.21

A new medium for the isolation of pathogenic Neisseria (NYC nmedium). 3. Performance as a culture and transport medium without addition of ambient carbon dioxide. Health Lab Sci (1973) 1.21

Transcellular transport and membrane insertion of the C5b-9 membrane attack complex of complement by glomerular epithelial cells in experimental membranous nephropathy. J Immunol (1989) 1.21